A Blinded Study to Evaluate Effect on Atrial Fibrillation Burden in Patients With Paroxysmal Atrial Fibrillation
Public ClinicalTrials.gov record NCT02156076. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled Parallel Arm Study to Evaluate the Safety, Tolerability, and Effect on Atrial Fibrillation Burden of BMS-919373 in Patients With Paroxysmal Atrial Fibrillation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the effect of BMS-919373 on atrial fibrillation (AF) through its effect on AF burden (AFB), or the percent of time in AF, in subjects with paroxysmal AF (pAF) when administered orally at a range of doses (2 mg once daily (QD), 5 mg QD, 12 mg QD following a 1-week period of loading doses of 3 mg QD, 8 mg QD and 20 mg QD, respectively) for a total of 4 weeks. It is hypothesized that treatment with BMS-919373 will reduce AF burden as compared to baseline relative to placebo.
Study identification
- NCT ID
- NCT02156076
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 158 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 25, 2014 (Actual)
- Primary completion
- Jun 1, 2016 (Actual)
- Completion
- Jun 1, 2016 (Actual)
- Last update posted
- Jul 31, 2019
2014 – 2016
United States locations
- U.S. sites
- 20
- U.S. states
- 12
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Cardiology Consultants Of Orange County Med. Group Inc | Anaheim | California | 92801 | — |
| Oracle Clinical Research, Inc. | Anaheim | California | 92801 | — |
| Wcct Global, Llc | Costa Mesa | California | 92626 | — |
| Long Beach Va Medical Center | Long Beach | California | 90822 | — |
| Spectrum Clinical Research | Moreno Valley | California | 92553 | — |
| Chase Medical Research, Llc | Waterbury | Connecticut | 06708 | — |
| All Medical Research, Llc | Cooper City | Florida | 33024 | — |
| The Cardiac And Vascular Institute Research Foundation, Llc | Gainesville | Florida | 32605 | — |
| Acrc Cardiology | Lake Worth | Florida | 33462 | — |
| The Heart Institute At Largo | Largo | Florida | 33770 | — |
| Columbus Regional Research Institute | Columbus | Georgia | 31904 | — |
| Community Clinical Research Center | Anderson | Indiana | 46011 | — |
| Midwest Heart And Vascular Specialists, Llc. | Overland Park | Kansas | 66209 | — |
| Cambridge Medical Trials | Alexandria | Louisiana | 71301 | — |
| Castlerock Clinical Research Consultants, Llc | Tulsa | Oklahoma | 74136 | — |
| Capital Area Research, Llc | Camp Hill | Pennsylvania | 17011 | — |
| Tennessee Center For Clinical Trials | Tullahoma | Tennessee | 37388 | — |
| Local Institution | Austin | Texas | 78705 | — |
| Local Institution | Austin | Texas | — | — |
| Utah Cardiology P.C | Layton | Utah | 84041 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02156076, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2019 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02156076 live on ClinicalTrials.gov.